Literature DB >> 22923352

Electrospun formulations containing crystalline active pharmaceutical ingredients.

Blair Kathryn Brettmann1, Kamyu Cheng, Allan S Myerson, Bernhardt L Trout.   

Abstract

PURPOSE: To investigate the use of electrospinning for forming solid dispersions containing crystalline active pharmaceutical ingredients (API) and understand the relevant properties of the resulting materials.
METHOD: Free surface electrospinning was used to prepare nanofiber mats of poly(vinyl pyrrolidone) (PVP) and crystalline albendazole (ABZ) or famotidine (FAM) from a suspension of the drug crystals in a polymer solution. SEM and DSC were used to characterize the dispersion, XRD was used to determine the crystalline polymorph, and dissolution studies were performed to determine the influence of the preparation method on the dissolution rate.
RESULTS: The electrospun fibers contained 31 wt% ABZ and 26 wt% FAM for the 1:2 ABZ:PVP and 1:2 FAM:PVP formulations, respectively, and both APIs retained their crystalline polymorphs throughout processing. The crystals had an average size of about 10 μm and were well-dispersed throughout the fibers, resulting in a higher dissolution rate for electrospun tablets than for powder tablets.
CONCLUSIONS: Previously used to produce amorphous formulations, electrospinning has now been demonstrated to be a viable option for producing fibers containing crystalline API. Due to the dispersion of the crystals in the polymer, tablets made from the fiber mats may also exhibit improved dissolution properties over traditional powder compression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923352     DOI: 10.1007/s11095-012-0868-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning.

Authors:  Geert Verreck; Iksoo Chun; Jef Peeters; Joel Rosenblatt; Marcus E Brewster
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 2.  Electrospun nanofibers in oral drug delivery.

Authors:  Francis Ignatious; Linghong Sun; Chao-Pin Lee; John Baldoni
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 3.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

4.  Free surface electrospinning of fibers containing microparticles.

Authors:  Blair K Brettmann; Shirley Tsang; Keith M Forward; Gregory C Rutledge; Allan S Myerson; Bernhardt L Trout
Journal:  Langmuir       Date:  2012-06-06       Impact factor: 3.882

5.  Effects of drug solubility, state and loading on controlled release in bicomponent electrospun fibers.

Authors:  Mădălina V Natu; Hermínio C de Sousa; M H Gil
Journal:  Int J Pharm       Date:  2010-07-03       Impact factor: 5.875

6.  Solid-state NMR characterization of high-loading solid solutions of API and excipients formed by electrospinning.

Authors:  Blair Brettmann; Erin Bell; Allan Myerson; Bernhardt Trout
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

7.  Enantiotropically related albendazole polymorphs.

Authors:  Marco B Pranzo; Dyanne Cruickshank; Massimo Coruzzi; Mino R Caira; Ruggero Bettini
Journal:  J Pharm Sci       Date:  2010-09       Impact factor: 3.534

8.  Mechanical properties of single electrospun drug-encapsulated nanofibres.

Authors:  Sing Yian Chew; Todd C Hufnagel; Chwee Teck Lim; Kam W Leong
Journal:  Nanotechnology       Date:  2006-08-14       Impact factor: 3.874

9.  Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer.

Authors:  Geert Verreck; Iksoo Chun; Joel Rosenblatt; Jef Peeters; Alex Van Dijck; Jurgen Mensch; Marc Noppe; Marcus E Brewster
Journal:  J Control Release       Date:  2003-10-30       Impact factor: 9.776

10.  Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.

Authors:  Patrick J Marsac; Tonglei Li; Lynne S Taylor
Journal:  Pharm Res       Date:  2008-09-09       Impact factor: 4.200

View more
  6 in total

1.  Drug-loaded zein nanofibers prepared using a modified coaxial electrospinning process.

Authors:  Weidong Huang; Tao Zou; Shengfang Li; Jinqiu Jing; Xianyou Xia; Xianli Liu
Journal:  AAPS PharmSciTech       Date:  2013-03-21       Impact factor: 3.246

Review 2.  In pursuit of functional electrospun materials for clinical applications in humans.

Authors:  Ryan J Stoddard; Arielle L Steger; Anna K Blakney; Kim A Woodrow
Journal:  Ther Deliv       Date:  2016-06-02

Review 3.  An overview of famotidine polymorphs: solid-state characteristics, thermodynamics, polymorphic transformation and quality control.

Authors:  Shan-Yang Lin
Journal:  Pharm Res       Date:  2014-03-01       Impact factor: 4.200

4.  Electrosprayed core-shell solid dispersions of acyclovir fabricated using an epoxy-coated concentric spray head.

Authors:  Zhe-Peng Liu; Lei Cui; Deng-Guang Yu; Zhuan-Xia Zhao; Lan Chen
Journal:  Int J Nanomedicine       Date:  2014-04-16

5.  Fabrication of Progesterone-Loaded Nanofibers for the Drug Delivery Applications in Bovine.

Authors:  Chitra Karuppannan; Mehnath Sivaraj; J Ganesh Kumar; Rangasamy Seerangan; S Balasubramanian; Dhinakar Raj Gopal
Journal:  Nanoscale Res Lett       Date:  2017-02-14       Impact factor: 4.703

6.  Monitoring of Antimicrobial Drug Chloramphenicol Release from Electrospun Nano- and Microfiber Mats Using UV Imaging and Bacterial Bioreporters.

Authors:  Liis Preem; Frederik Bock; Mariliis Hinnu; Marta Putrinš; Kadi Sagor; Tanel Tenson; Andres Meos; Jesper Østergaard; Karin Kogermann
Journal:  Pharmaceutics       Date:  2019-09-19       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.